▁Bre 10.375
ast 6.77734375
▁cancer 7.69921875
▁is 6.69140625
▁a 1.7841796875
▁complex 6.05859375
▁disease 1.25
▁influenced 9.5859375
▁by 0.8515625
▁a 2.724609375
▁mult 4.74609375
itude 0.56103515625
▁of 0.3798828125
▁critical 7.97265625
▁factors 4.66796875
, 2.509765625
▁including 4.0078125
▁her 7.7578125
ed 4.48046875
ity 5.1015625
, 1.1201171875
▁dise 7.5859375
ases 2.423828125
▁of 3.1796875
▁the 2.71875
▁m 7.26171875
amm 2.9296875
ary 1.01953125
▁g 7.36328125
lands 2.439453125
, 0.77490234375
▁and 2.943359375
▁h 6.4453125
orm 3.724609375
onal 5.52734375
▁im 7.40234375
bal 1.212890625
ances 0.1685791015625
. 0.80126953125
▁Under 7.4765625
standing 1.10546875
▁these 2.95703125
▁factors 2.35546875
▁is 1.724609375
▁p 5.5625
iv 0.0038585662841796875
otal 0.00039768218994140625
▁in 1.5
▁compreh 5.42578125
ending 0.09674072265625
▁the 0.9248046875
▁development 5.7109375
▁of 0.55810546875
▁breast 5.2734375
▁cancer 0.336669921875
▁and 1.8076171875
▁implementing 7.01953125
▁effective 2.90234375
▁prevent 2.384765625
ion 1.2978515625
▁strateg 1.5419921875
ies 0.000324249267578125
. 0.471435546875
<0x0A> 1.2958984375
H 4.31640625
ered 6.01953125
ity 0.03472900390625
▁plays 4.02734375
▁a 0.3056640625
▁significant 1.9140625
▁role 0.043212890625
▁in 0.0401611328125
▁breast 2.001953125
▁cancer 0.040802001953125
▁sus 4.19140625
cept 0.0001990795135498047
ibility 0.0016145706176757812
. 0.837890625
▁Ind 5.74609375
ividual 0.058380126953125
s 0.209228515625
▁with 0.728515625
▁a 0.7138671875
▁family 1.0400390625
▁history 0.0240478515625
▁of 0.049835205078125
▁the 3.66796875
▁disease 0.0751953125
, 2.4296875
▁especially 2.9140625
▁those 2.482421875
▁carrying 3.443359375
▁specific 4.10546875
▁gen 1.3251953125
etic 0.414794921875
▁mut 0.84912109375
ations 0.00969696044921875
▁such 3.349609375
▁as 0.007450103759765625
▁BR 0.377685546875
CA 0.0032958984375
1 0.299072265625
▁and 0.66845703125
▁BR 0.073974609375
CA 0.0027179718017578125
2 0.0116729736328125
, 0.25439453125
▁are 0.60546875
▁at 0.357421875
▁a 1.1884765625
▁higher 0.8662109375
▁risk 0.022857666015625
. 2.396484375
▁These 2.595703125
▁mut 0.70068359375
ations 0.0183868408203125
▁imp 4.9921875
air 0.334716796875
▁the 0.74609375
▁body 3.8203125
' 0.008087158203125
s 0.0005373954772949219
▁ability 0.4267578125
▁to 0.002330780029296875
▁suppress 8.0703125
▁tum 2.525390625
or 0.28076171875
▁growth 0.78369140625
▁and 1.09765625
▁repair 4.4609375
▁DNA 0.798828125
. 2.716796875
▁Close 9.828125
▁relatives 0.78955078125
▁of 0.51611328125
▁affected 3.986328125
▁individuals 0.420654296875
▁should 4.84375
▁under 2.208984375
go 0.0002562999725341797
▁gen 1.02734375
etic 0.00962066650390625
▁coun 1.08984375
sel 0.06732177734375
ing 0.0006704330444335938
▁and 1.291015625
▁testing 1.2724609375
▁to 0.99169921875
▁determine 1.208984375
▁their 0.98046875
▁own 2.759765625
▁risk 0.7099609375
▁and 2.939453125
▁make 4.32421875
▁informed 1.423828125
▁dec 0.20556640625
isions 1.6808509826660156e-05
▁regarding 1.2197265625
▁prevent 2.5546875
ive 0.5556640625
▁measures 0.908203125
, 3.330078125
▁such 1.1201171875
▁as 0.0034694671630859375
▁regular 3.353515625
▁screen 1.849609375
ings 0.8173828125
▁or 3.646484375
▁pro 2.458984375
phy 0.0157623291015625
la 0.0014905929565429688
ctic 0.0129241943359375
▁surg 2.11328125
ery 0.083984375
. 0.2176513671875
<0x0A> 0.34765625
D 1.802734375
ise 1.109375
ases 0.2900390625
▁of 0.249755859375
▁the 0.06787109375
▁m 0.275390625
amm 0.00193023681640625
ary 0.001438140869140625
▁g 0.01337432861328125
lands 0.08013916015625
, 2.25390625
▁such 1.5537109375
▁as 0.0034885406494140625
▁at 5.34765625
yp 0.341552734375
ical 0.04180908203125
▁hyper 0.30322265625
pl 0.010589599609375
asia 0.0297088623046875
▁or 2.84375
▁car 1.9931640625
cin 0.03564453125
oma 0.042877197265625
▁in 0.125
▁situ 0.0078277587890625
, 0.28125
▁can 1.9150390625
▁increase 3.75
▁the 0.7587890625
▁risk 0.195556640625
▁of 0.1915283203125
▁breast 0.64013671875
▁cancer 0.004413604736328125
. 0.623046875
▁These 1.9111328125
▁conditions 1.5595703125
▁involve 3.576171875
▁ab 1.7333984375
normal 0.0034313201904296875
▁cell 1.76171875
ular 2.953125
▁growth 0.61279296875
▁or 2.751953125
▁pre 5.69140625
can 0.2108154296875
cer 0.0035247802734375
ous 0.028533935546875
▁changes 0.51220703125
▁in 0.80810546875
▁the 0.318603515625
▁breast 1.1025390625
▁t 0.7861328125
issue 0.07318115234375
. 0.697265625
▁Reg 5.859375
ular 0.01708984375
▁breast 2.01953125
▁exam 1.7490234375
in 0.12548828125
ations 2.7060508728027344e-05
▁and 0.82373046875
▁m 1.107421875
amm 0.00014221668243408203
og 0.68603515625
rams 0.00014638900756835938
▁are 0.9765625
▁cru 2.8671875
cial 0.001434326171875
▁in 0.55615234375
▁detect 0.63623046875
ing 6.914138793945312e-05
▁these 0.765625
▁dise 3.115234375
ases 0.00046181678771972656
▁at 2.41796875
▁an 0.398681640625
▁early 0.048004150390625
▁stage 0.024139404296875
▁when 2.494140625
▁they 1.1611328125
▁are 0.445068359375
▁highly 4.55078125
▁treat 0.32470703125
able 0.00015020370483398438
. 0.328125
▁Prom 7.421875
pt 0.047393798828125
▁diagn 1.80859375
osis 0.02386474609375
▁and 0.296875
▁appropriate 3.353515625
▁inter 4.41015625
vent 1.419921875
ions 0.0091400146484375
▁can 1.0009765625
▁reduce 2.072265625
▁the 0.321533203125
▁lik 3.541015625
elihood 0.0008907318115234375
▁of 0.042236328125
▁m 3.71875
align 0.157958984375
ant 0.7490234375
▁transformation 0.90625
▁and 1.49609375
▁the 2.80078125
▁subsequent 3.513671875
▁development 1.263671875
▁of 0.0041046142578125
▁invas 2.2265625
ive 0.0003116130828857422
▁breast 0.55810546875
▁cancer 0.053009033203125
. 0.063720703125
<0x0A> 0.09625244140625
H 1.5146484375
orm 0.0038433074951171875
onal 0.1905517578125
▁factors 3.435546875
▁also 2.720703125
▁contribute 2.53125
▁significantly 2.76953125
▁to 0.0154876708984375
▁the 0.440185546875
▁development 0.281494140625
▁of 0.0662841796875
▁breast 0.08111572265625
▁cancer 0.0050048828125
. 0.10296630859375
▁Est 2.296875
ro 0.16748046875
gen 5.7220458984375e-05
▁and 1.080078125
▁pro 0.0733642578125
g 0.01432037353515625
ester 3.719329833984375e-05
one 0.0010595321655273438
▁re 2.619140625
cept 0.114013671875
ors 7.95125961303711e-05
, 1.8603515625
▁prote 5.62109375
ins 0.0016813278198242188
▁found 2.90625
▁on 1.5498046875
▁breast 2.53515625
▁cells 0.599609375
, 0.391357421875
▁interact 4.5390625
▁with 0.0926513671875
▁these 4.5625
▁h 0.1572265625
orm 2.384185791015625e-07
ones 0.010467529296875
▁and 1.74609375
▁promote 3.666015625
▁cell 1.5859375
▁growth 0.70654296875
. 0.90625
▁A 3.998046875
▁prolong 6.23046875
ed 0.0021495819091796875
▁expos 1.56640625
ure 2.181529998779297e-05
▁to 0.045654296875
▁elev 4.82421875
ated 0.0007333755493164062
▁h 2.892578125
orm 1.6689300537109375e-05
onal 2.966796875
▁levels 0.1402587890625
, 1.69921875
▁either 2.755859375
▁due 2.228515625
▁to 0.000743865966796875
▁early 4.91015625
▁men 1.1552734375
stru 1.74609375
ation 0.127685546875
, 1.8837890625
▁late 4.1640625
▁men 0.6943359375
op 0.0810546875
ause 0.004192352294921875
, 0.15625
▁or 0.2509765625
▁the 2.359375
▁use 0.5087890625
▁of 0.00316619873046875
▁h 1.068359375
orm 2.205371856689453e-05
one 0.28369140625
▁replacement 0.8427734375
▁ther 0.0286865234375
apy 0.2286376953125
, 0.2626953125
▁increases 1.455078125
▁the 0.25537109375
▁risk 0.10833740234375
▁of 0.06280517578125
▁breast 0.55126953125
▁cancer 0.01580810546875
. 0.259765625
▁Under 6.9296875
standing 0.19384765625
▁the 0.58837890625
▁h 2.267578125
orm 5.2928924560546875e-05
onal 0.10693359375
▁profile 3.8359375
▁of 0.2200927734375
▁an 1.5205078125
▁individual 0.0419921875
▁can 1.7568359375
▁aid 3.150390625
▁in 0.1134033203125
▁de 8.0625
vis 0.056304931640625
ing 1.5020370483398438e-05
▁personal 3.0390625
ized 0.050567626953125
▁prevent 0.57861328125
ion 0.8671875
▁strateg 0.296875
ies 3.814697265625e-06
, 1.8427734375
▁such 0.5791015625
▁as 0.0016422271728515625
▁h 2.54296875
orm 0.003932952880859375
one 0.18896484375
- 1.8466796875
block 3.18359375
ing 0.05072021484375
▁medic 0.97705078125
ations 0.1766357421875
▁or 1.5859375
▁l 4.140625
ifest 0.0027008056640625
yle 0.0007457733154296875
▁modifications 1.0146484375
. 0.78662109375
<0x0A> 0.0889892578125
Det 7.6328125
ect 1.3896484375
ing 0.034332275390625
▁early 3.314453125
▁met 7.96484375
ast 0.0186309814453125
asis 2.1171875
▁is 1.6044921875
▁cru 1.337890625
cial 0.0009851455688476562
▁in 0.40283203125
▁determ 3.623046875
ining 7.367134094238281e-05
▁the 0.34814453125
▁pro 1.7294921875
gn 0.0191802978515625
osis 0.00214385986328125
▁and 1.5478515625
▁treatment 1.2158203125
▁of 0.62353515625
▁breast 0.229248046875
▁cancer 0.00559234619140625
. 0.09783935546875
▁Met 1.7978515625
ast 0.004726409912109375
asis 0.498291015625
▁occurs 1.4609375
▁when 0.084716796875
▁cancer 0.51025390625
▁cells 0.10107421875
▁spread 0.96923828125
▁from 0.74658203125
▁the 0.340576171875
▁primary 0.35498046875
▁tum 0.38232421875
or 0.00873565673828125
▁to 0.2408447265625
▁other 0.335693359375
▁parts 1.6240234375
▁of 0.0007658004760742188
▁the 0.0012941360473632812
▁body 0.01470184326171875
, 0.8935546875
▁leading 4.23046875
▁to 0.0053558349609375
▁a 2.189453125
▁more 2.349609375
▁advanced 1.4873046875
▁stage 0.580078125
▁of 0.1982421875
▁the 0.427734375
▁disease 0.024169921875
. 0.2705078125
▁Reg 4.42578125
ular 0.003574371337890625
▁screen 0.958984375
ings 0.28955078125
, 1.39453125
▁such 0.7021484375
▁as 0.0014133453369140625
▁m 0.227294921875
amm 0.00010955333709716797
og 0.468994140625
rams 4.601478576660156e-05
, 0.86572265625
▁help 2.857421875
▁identify 2.025390625
▁breast 2.830078125
▁cancer 0.277099609375
▁at 0.56640625
▁an 0.274169921875
▁early 0.1558837890625
▁stage 0.039947509765625
▁before 3.810546875
▁it 0.896484375
▁has 0.61181640625
▁had 3.55078125
▁the 2.263671875
▁chance 1.1484375
▁to 0.002353668212890625
▁spread 0.77978515625
. 0.693359375
▁Additionally 5.18359375
, 0.0007200241088867188
▁special 6.0703125
ized 0.31689453125
▁imag 0.83203125
ing 0.0033092498779296875
▁techniques 0.72119140625
, 0.74169921875
▁such 0.199951171875
▁as 0.0016489028930664062
▁M 3.291015625
RI 0.0108184814453125
▁or 2.556640625
▁P 0.931640625
ET 0.0003542900085449219
▁sc 0.48046875
ans 0.116455078125
, 0.0167694091796875
▁can 0.875
▁help 2.43359375
▁detect 0.9580078125
▁met 1.0078125
ast 0.0005431175231933594
atic 0.58642578125
▁les 3.224609375
ions 0.0004153251647949219
▁in 2.177734375
▁distant 6.234375
▁org 0.8046875
ans 9.059906005859375e-06
. 1.005859375
▁Tim 6.578125
ely 0.0025920867919921875
▁detection 1.9033203125
▁of 1.640625
▁met 0.24560546875
ast 0.0004260540008544922
asis 1.0986328125
▁allows 1.810546875
▁for 0.482177734375
▁the 1.875
▁implementation 1.6982421875
▁of 0.0032501220703125
▁target 2.017578125
ed 0.0015869140625
▁ther 0.68115234375
ap 0.1217041015625
ies 1.621246337890625e-05
▁and 1.6259765625
▁impro 4.44140625
ves 0.033172607421875
▁patient 3.609375
▁out 0.34619140625
comes 0.006744384765625
. 0.044891357421875
<0x0A> 0.0643310546875
Det 6.36328125
erm 0.78369140625
ining 0.0296783447265625
▁the 0.5205078125
▁ag 5.87109375
gress 0.005336761474609375
iveness 0.040618896484375
▁of 0.084716796875
▁breast 0.51171875
▁cancer 0.01062774658203125
▁is 0.587890625
▁essential 2.06640625
▁for 1.8876953125
▁determ 1.2568359375
ining 0.00019359588623046875
▁the 0.47509765625
▁most 1.9580078125
▁suitable 3.7109375
▁treatment 0.284912109375
▁plan 2.47265625
. 0.2313232421875
▁Path 6.796875
olog 0.58740234375
ists 1.708984375
▁analyze 4.48828125
▁tum 1.65625
or 0.09063720703125
▁samples 2.326171875
▁to 0.99072265625
▁identify 1.9091796875
▁specific 3.4765625
▁cell 3.447265625
ular 0.77099609375
▁characteristics 1.47265625
, 0.9677734375
▁such 0.4580078125
▁as 0.00113677978515625
▁the 1.3486328125
▁tum 4.22265625
or 0.002536773681640625
▁grade 1.6787109375
▁or 1.791015625
▁the 1.45703125
▁presence 1.1708984375
▁of 0.07733154296875
▁specific 2.34765625
▁bi 5.30078125
om 0.119384765625
ark 0.00362396240234375
ers 0.0137939453125
▁like 5.1015625
▁human 3.93359375
▁e 0.041778564453125
pid 0.0006651878356933594
erm 0.02191162109375
al 0.0005593299865722656
▁growth 0.00547027587890625
▁factor 0.00885772705078125
▁re 0.0966796875
ceptor 0.05780029296875
▁ 0.1656494140625
2 0.0009732246398925781
▁( 0.48193359375
HER 0.01641845703125
2 0.0750732421875
). 0.6923828125
▁These 1.49609375
▁factors 2.72265625
▁allow 3.6640625
▁health 5.41015625
care 0.1795654296875
▁profession 0.8037109375
als 1.1920928955078125e-06
▁to 0.007740020751953125
▁recommend 5.32421875
▁appropriate 2.390625
▁treatment 0.85302734375
▁options 0.7109375
, 0.70849609375
▁including 1.306640625
▁surg 0.7978515625
ery 0.34912109375
, 0.17041015625
▁chem 0.783203125
other 0.0088653564453125
apy 0.003971099853515625
, 0.0250701904296875
▁radiation 2.119140625
▁ther 0.312255859375
apy 0.0026378631591796875
, 0.0105743408203125
▁or 0.5615234375
▁target 1.4619140625
ed 0.00316619873046875
▁ther 0.320068359375
apy 1.13671875
. 0.22998046875
<0x0A> 0.53662109375
In 3.58984375
▁conclusion 2.1953125
, 0.0011577606201171875
▁breast 0.59814453125
▁cancer 0.00691986083984375
▁development 5.49609375
▁is 0.432373046875
▁influenced 2.39453125
▁by 0.01434326171875
▁critical 10.1171875
▁factors 0.386474609375
▁such 1.00390625
▁as 0.002635955810546875
▁her 0.740234375
ed 0.038665771484375
ity 0.00022161006927490234
, 0.06646728515625
▁dise 1.5849609375
ases 0.0010433197021484375
▁of 0.0178375244140625
▁the 0.0141143798828125
▁m 0.002719879150390625
amm 0.0013666152954101562
ary 0.0002734661102294922
▁g 0.0028972625732421875
lands 0.0263824462890625
, 0.0281219482421875
▁and 2.1328125
▁h 0.0787353515625
orm 5.9604644775390625e-06
onal 0.08221435546875
▁im 1.7919921875
bal 0.0008673667907714844
ances 0.0458984375
. 0.130859375
▁Det 3.71875
ect 0.56640625
ing 0.0005664825439453125
▁early 0.68115234375
▁met 0.1005859375
ast 5.233287811279297e-05
asis 0.09039306640625
▁and 1.630859375
▁understanding 3.69921875
▁the 0.19091796875
▁ag 0.5478515625
gress 0.00025343894958496094
iveness 0.00323486328125
▁of 0.01444244384765625
▁the 0.5673828125
▁cancer 3.130859375
▁type 7.76171875
▁play 4.4609375
▁a 0.72607421875
▁substantial 6.06640625
▁role 0.0051422119140625
▁in 0.0012407302856445312
▁tail 5.22265625
oring 0.005886077880859375
▁treatment 1.4091796875
▁approaches 3.9453125
▁and 1.13671875
▁impro 0.52978515625
ving 9.608268737792969e-05
▁patient 0.34814453125
▁out 0.038818359375
comes 0.0003533363342285156
. 0.00502777099609375
▁Through 4.6953125
▁increased 4.61328125
▁aw 0.39697265625
aren 5.078315734863281e-05
ess 1.5020370483398438e-05
, 1.787109375
▁gen 7.44140625
etic 0.012451171875
▁testing 1.4833984375
, 0.051177978515625
▁regular 4.33203125
▁screen 0.2176513671875
ings 0.095947265625
, 0.03668212890625
▁and 0.1595458984375
▁improved 4.76171875
▁di 1.740234375
agnostic 0.1536865234375
▁methods 2.630859375
, 0.020538330078125
▁we 2.1640625
▁can 0.263916015625
▁enh 5.7109375
ance 1.8835067749023438e-05
▁early 2.7734375
▁detection 0.197265625
, 1.7265625
▁inter 3.7421875
vention 0.401123046875
, 0.041534423828125
▁and 0.0283203125
▁prevent 1.5078125
ion 0.04254150390625
▁strateg 1.4150390625
ies 4.410743713378906e-06
, 2.6171875
▁ultimately 2.23828125
▁reducing 0.91748046875
▁the 0.2110595703125
▁impact 3.3671875
▁of 0.06396484375
▁breast 0.322265625
▁cancer 0.0008525848388671875
▁on 0.74072265625
▁individuals 1.6005859375
▁and 0.701171875
▁society 0.7578125
▁as 1.8544921875
▁a 0.00335693359375
▁whole 0.00016808509826660156
. 0.00131988525390625
